High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
Clinical trial NCT00288626 · COMPLETED
Trial details
- NCT number
- NCT00288626
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2015-11-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.